Interview with Dr. Chetan Tamhankar, Chief Executive Officer, SIRO Clinpharm Pvt…
Undeniably, the landscape for CROs has dramatically changed compared to when you started in the 1990s. The idea of…
Address: SIRO Clinpharm Pvt Ltd, DIL Premises, Swami Vivekanand Road, Near Tatvagyan Vidyapeeth, Ghodbunder Road, Thane (W) 400 610, India
Tel: +91 22 2584 8000
Web: http://www.siroclinpharm.com/
SIRO Clinpharm Private Limited (SIRO) is among one of the leading global Clinical Research Organizations (CROs), offering full scope services, conducting clinical trials for the pharmaceutical, biotechnology and medical devices sectors in compliance with international standards. SIRO is one of the first CROs founded in India, which caters to the needs of pharmaceutical companies across the world. The company has offices in India, USA, Israel, Germany, Romania, Estonia and Greece. SIRO has recently opened offices in Czech Republic & Spain. For more information, visit http://www.siroclinpharm.com.
Mission
We will provide exceptional drug development solutions through our passion for excellence and unwavering commitment.
To achieve our mission, we will
Undeniably, the landscape for CROs has dramatically changed compared to when you started in the 1990s. The idea of…
The latest news from Indian pharma, including a 200 percent boost for the country’s pharmaceutical industry in…
The USD 41 billion Indian pharma industry, the world’s third largest by volume and 13th largest by value, stands…
Six Indian pharma and biotech firms have joined the global race to develop a vaccine for COVID-19 with…
COVID-19 restrictions have severely hampered multinational pharma companies who rely on India for generics and…
A recent IQVIA report highlights the increasing importance of Indian firms to the USA’s burgeoning generic…
The ongoing coronavirus outbreak and the subsequent shutdown of factories in China is having severe repercussions…
Below is a selection of the top stories in Indian pharma from recent months, ranging from efforts to counter the…
Biocon, the first Indian company to have a biosimilar drug approved in the US, is taking another step forward with…
The state of Gujarat proudly stands as India’s main pharmaceutical hub, accounting for over 33 percent of the…
Unlike many of his pharma peers, Vivek Sharma worked in operations and finance for two decades before joining the…
The pharmaceutical industries of China and India, historically focused on their large domestic markets and exports…
Aditya Bhattacharji is Healthcare Practice Head at Eurasia Group. In this article, he looks at India’s…